Select Page

The global nuclear medicines radioisotopes market is expected to rise with an impressive CAGR and generate the highest revenue by 2026. Fortune Business Insights™ in its latest report published this information. The report is titled “Nuclear Medicines Radioisotopes Market Size, Share and Global Trend By Product Type (Diagnostics, Therapeutic), By Application (Oncology, Gastroenterology, Neurology, Orthopedics,Others), By End-user (Hospitals, Diagnostic centers, Specialty clinics, Education and research institutes, Others) and Geography Forecast till 2026”. The report discusses research objectives, research scope, methodology, timeline and challenges during the entire forecast period. It also offers an exclusive insight into various details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies.

For more information, Get sample pdf @ https://www.fortunebusinessinsights.com/industry-reports/nuclear-medicines-radioisotopes-market-101055

The report provides a 360-degree overview of the market, listing various factors restricting, propelling, and obstructing the market in the forecast duration. The report also provides additional information such as interesting insights, key industry developments, detailed segmentation of the market, list of prominent players operating in the market, and other nuclear medicines radioisotopes market trends. The report is available for sale on the company website.

List of companies cover in the research report are:

  • Siemens Healthcare Private Limited
  • Bayer
  • Hologic
  • Cardinal Health
  • Positron Corporation
  • General Electric Company
  • Aenorasis

Nuclear medicines are used for imaging purposes and the procedures are carried out using radiotracers. These radiotracers are essentially molecules linked with a very small amount of radioactive material. They are then injected, swallowed or inhaled. The radiotracer travels in the area under inspection through the bloodstream and emanates signals or energy in the form of gamma rays, which is detected on the PET scan camera. A radioisotope is an artificially produced isotope that has an unnatural combination of protons and neutrons.

View press release for more information @ https://www.medgadget.com/2019/11/nuclear-medicines-radioisotopes-market-size-share-analysis-value-growth-outlook-2026-research-report-by-fortune-business-insights.html

Regional Analysis for Nuclear Medicines Radioisotopes Market:

  • North America (the USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)

Major Table of Contents for Nuclear Medicines Radioisotopes Market:

  1. Introduction
  2. Executive Summary
  3. Market Dynamics
  4. Key Nuclear Medicines Radioisotopes Market Insights
  5. Global Market Analysis, Insights and Forecast, 2015-2026
  6. North America Market Analysis, Insights and Forecast, 2015-2026
  7. Europe Market Analysis, Insights and Forecast, 2015-2026
  8. Asia Pacific Market Analysis, Insights and Forecast, 2015-2026
  9. The Middle East and Africa Market Analysis, Insights and Forecast, 2015-2026
  10. Latin America Market Analysis, Insights and Forecast, 2015-2026
  11. Competitive Landscape
  12. Global Nuclear Medicines Radioisotopes Market Revenue Share Analysis, By Key Players, 2020
  13. Company Profiles
  14. Conclusion

Other Exclusive Reports:

Diabetic Neuropathy Market

Lymphoma Treatment Market

Neonatal Intensive Care Market

Monoclonal Antibody Therapy Market

Pharmacovigilance Market

Skin Cancer Treatment Market

Alopecia Treatment Market

Dermatology Laser Market

Exosomes Market

Non-steroidal Anti-Inflammatory Drugs [NSAIDs] Market

Personal Emergency Response Systems Market

About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact:
Name: Ashwin Arora